US Lawyer Database

Section 15-1617 – Required Policies, Procedures, and Processes

    A pharmacy benefits manager shall ensure that its pharmacy and therapeutics committee has:         (1)    policies and procedures, including disclosure requirements, to address potential conflicts of interest that members of the pharmacy and therapeutics committee may have with developers or manufacturers of prescription drugs;         (2)    a process to evaluate medical and scientific evidence concerning the safety and effectiveness […]

Section 15-1618 – Accreditation

    The Commissioner may consider a pharmacy and therapeutics committee of a pharmacy benefits manager as having met the requirements of §§ 15–1614 and 15–1617 of this part if the pharmacy benefits manager has obtained accreditation from an accrediting organization approved by the Commissioner.

Section 15-1613 – In General

    A pharmacy and therapeutics committee established by a pharmacy benefits manager performing pharmacy benefits management services on behalf of a carrier shall meet the requirements of this part.

Section 15-1614 – Composition; Conflict of Interest Statement

    (a)    (1)    A pharmacy and therapeutics committee shall:             (i)    include clinical specialists that represent the needs of a purchaser’s beneficiaries; and             (ii)    include at least one practicing pharmacist and one practicing physician who are independent of any developer or manufacturer of prescription drugs.         (2)    A majority of the members of a pharmacy and therapeutics committee shall be practicing physicians or […]

Section 15-1616 – Disclosure About Composition

    On request of a purchaser for which the pharmacy and therapeutics committee makes recommendations, a pharmacy benefits manager shall disclose information about the composition of its pharmacy and therapeutics committee to the purchaser.